These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16481549)

  • 1. Mechanisms of immunological control of Anaplasma phagocytophilum in mice.
    Rinkler C; Kern Y; Bogdan C; Von Loewenich FD
    Ann N Y Acad Sci; 2005 Dec; 1063():411-2. PubMed ID: 16481549
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-gamma deficiency reveals that 129Sv mice are inherently more susceptible to Anaplasma phagocytophilum than C57BL/6 mice.
    Wang T; Akkoyunlu M; Banerjee R; Fikrig E
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):299-305. PubMed ID: 15477043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Msp2 variation in Anaplasma phagocytophilum in vivo does not stimulate T cell immune responses or interferon-gamma production.
    Choi KS; Scorpio DG; Barat NC; Stephen Dumler J
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):374-86. PubMed ID: 17286796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury.
    Scorpio DG; von Loewenich FD; Göbel H; Bogdan C; Dumler JS
    Clin Vaccine Immunol; 2006 Jul; 13(7):806-9. PubMed ID: 16829620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load.
    Scorpio DG; Von Loewenich FD; Bogdan C; Dumler JS
    Ann N Y Acad Sci; 2005 Dec; 1063():425-8. PubMed ID: 16481553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions.
    Borjesson DL; Barthold SW
    Comp Med; 2002 Oct; 52(5):403-13. PubMed ID: 12405632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.
    Sukumaran B; Ogura Y; Pedra JH; Kobayashi KS; Flavell RA; Fikrig E
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):211-9. PubMed ID: 22747758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum.
    Blas-Machado U; de la Fuente J; Blouin EF; Almazán C; Kocan KM; Mysore JV
    Vet Pathol; 2007 Jan; 44(1):64-73. PubMed ID: 17197625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling.
    Choi KS; Dumler JS
    Microbiol Immunol; 2013 Mar; 57(3):207-12. PubMed ID: 23278812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation.
    Wang X; Shaw DK; Hammond HL; Sutterwala FS; Rayamajhi M; Shirey KA; Perkins DJ; Bonventre JV; Velayutham TS; Evans SM; Rodino KG; VieBrock L; Scanlon KM; Carbonetti NH; Carlyon JA; Miao EA; McBride JW; Kotsyfakis M; Pedra JH
    PLoS Pathog; 2016 Aug; 12(8):e1005803. PubMed ID: 27482714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of sustained-release doxycycline blocks tick-transmitted infection by Anaplasma phagocytophilum in a murine model.
    Massung RF; Zeidner NS; Dolan MC; Roellig D; Gabitzsch E; Troughton DR; Levin ML
    Ann N Y Acad Sci; 2005 Dec; 1063():436-8. PubMed ID: 16481556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein-2 and CXCR2 expression in apolipoprotein E-deficient mice.
    Xiong Q; Wang X; Rikihisa Y
    J Infect Dis; 2007 May; 195(10):1497-503. PubMed ID: 17436230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of antibodies to Anaplasma phagocytophilum in Antalya, Turkey.
    Ongut G; Ogunc D; Mutlu G; Colak D; Gultekin M; Gunseren F; Donmez L; Tuncer D
    Infection; 2006 Apr; 34(2):107-9. PubMed ID: 16703304
    [No Abstract]   [Full Text] [Related]  

  • 14. The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms.
    Birkner K; Steiner B; Rinkler C; Kern Y; Aichele P; Bogdan C; von Loewenich FD
    Eur J Immunol; 2008 Dec; 38(12):3395-410. PubMed ID: 19039769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Anaplasma phagocytophilum among healthy dogs and horses in Israel.
    Levi O; Waner T; Baneth G; Keysary A; Bruchim Y; Silverman J; Harrus S
    J Vet Med B Infect Dis Vet Public Health; 2006 Mar; 53(2):78-80. PubMed ID: 16626404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Anaplasma phagocytophilum in a high-risk human population.
    Chochlakis D; Ioannou I; Kokkini I; Tselentis Y; Psaroulaki A
    J Infect; 2009 Jan; 58(1):87-8. PubMed ID: 19081633
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory Maintenance of Anaplasma phagocytophilum.
    Carlyon JA
    Curr Protoc Microbiol; 2005 Jul; Chapter 3():Unit 3A.2. PubMed ID: 18770564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reservoir competency of goats for Anaplasma phagocytophilum.
    Massung RF; Levin ML; Miller NJ; Mather TN
    Ann N Y Acad Sci; 2006 Oct; 1078():476-8. PubMed ID: 17114757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: serologic evidence of human ehrlichiosis in Peru.
    Moro PL; Shah J; Li O; Gilman RH; Harris N; Moro MH
    Am J Trop Med Hyg; 2009 Feb; 80(2):242-4. PubMed ID: 19190221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of Anaplasma phagocytophilum infection in dogs in Germany].
    Barutzki D; De Nicola A; Zeziola M; Reule M
    Berl Munch Tierarztl Wochenschr; 2006; 119(7-8):342-7. PubMed ID: 17009720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.